Clinical Trials
2 trialsNCT06455046 2024-06-12
Efficacy and Safety of AK104 Combined With Chemotherapy and Recombinant Human Adenovirus 5 Injection in Cervical Cancer
Fujian Cancer Hospital
Phase 2 Recruiting
NCT06063018 2023-10-02
RC48 Combined With Tislelizumab for Second-line Treatment of HER2 Expression in Recurrent Cervical Cancer
Peking Union Medical College Hospital
Phase 2 Recruiting